Filtered By:
Specialty: Cardiology
Condition: Renal Failure
This page shows you your search results in order of date. This is page number 4.
Order by Relevance | Date
Total 441 results found since Jan 2013.
A comparative study of intravenous labetalol VS intravenous Nitroglycerin in the treatment of hypertensive crises
Indian Heart J. 2022 Jun 3:S0019-4832(22)00097-9. doi: 10.1016/j.ihj.2022.06.001. Online ahead of print.ABSTRACTHypertensive crises is still a major public health problem, causing end organ damage like myocardial infarction, stroke, and renal failure. Labetalol and nitroglycerine are among the two most commonly used medicine to control the blood pressure, but there is no head to head comparison between these two medicines. This was a prospective randomized non-blinded study which included 50 patients of hypertensive crises, out which 25 patients received intravenous labetalol and 25 patients received intravenous nitroglyce...
Source: Indian Heart J - June 6, 2022 Category: Cardiology Authors: M O H A M M A D A Z H A R U D D I N Malik R E H A N Ahmad M U J A H I D Beg R I Z W A N Ahmad Source Type: research
One-Stop Hybrid Coronary Revascularization Versus Off-Pump Coronary Artery Bypass Grafting
Int Heart J. 2022;63(3):441-446. doi: 10.1536/ihj.21-705.ABSTRACTOne-stop hybrid coronary revascularization (HCR) is a promising revascularization strategy for treating multivessel coronary artery disease (MVCAD). However, its safety and feasibility remain controversial. Therefore, we introduced our experience with midterm follow-up of HCR in patients with MVCAD and compared it with conventional off-pump coronary artery bypass grafting (CABG).Patients with MVCAD undergoing one-stop HCR at Beijing Chaoyang Hospital between March 2018 and December 2020 were retrospectively enrolled. These patients were matched in a 1:2 ratio...
Source: International Heart Journal - June 1, 2022 Category: Cardiology Authors: Yanyan Li Zhiyong Zhang Jie Gao Chuang Li Kuibao Li Pixiong Su Lefeng Wang Source Type: research
